Comparison Tscan Therapeutics (TCRX) with Competitors
Tscan Therapeutics (TCRX) industry is Biotechnology.
Operating Margin
TCRX-1476.00%
Industry-2073.25%
Upside+597.25%
Debt-to-Equity
TCRX22.51%
Industry29.76%
Upside-24.37%
P/E
TCRX-0.99
Industry-18.88
Upside+1789.22%
P/S
TCRX7.14
Industry9.28
Upside-23.11%
P/B
TCRX0.42
Industry4.70
Upside-91.11%